Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle – Wants To Cut Billions In Costs. Here Are The Stocks Affected
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including:
